Literature DB >> 25691772

Molecular pathways: trafficking of metabolic resources in the tumor microenvironment.

Iris L Romero1, Abir Mukherjee1, Hilary A Kenny1, Lacey M Litchfield1, Ernst Lengyel2.   

Abstract

A model of tumor metabolism is proposed that describes how the complementary metabolic functions of the local stroma and the tumor cells contribute to cancer progression. Cancer cells alter the metabolism of cancer-associated fibroblasts to obtain lactate and amino acids, which are utilized for energy production, rapid growth, and resistance to chemotherapy drugs. Cancer cells use glutamine supplied by cancer-associated fibroblasts to replenish tricarboxylic acid cycle intermediates and as a nitrogen source for nucleotide synthesis. Moreover, adipocytes in the microenvironment attract cancer cells through the secretion of inflammatory cytokines and proteases. The cancer cells then induce metabolic changes in the adipocytes to acquire free fatty acids that are oxidized by cancer cells to generate energy for proliferation. Increasing knowledge about the metabolic symbiosis within the tumor has led to novel therapeutic strategies designed to restrict metabolic adaptation, including inhibiting lactate transporters and repurposing antidiabetic drugs (thiazolidinediones, metformin). ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2015        PMID: 25691772      PMCID: PMC4333734          DOI: 10.1158/1078-0432.CCR-14-2198

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  52 in total

Review 1.  Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer.

Authors:  Y Liu
Journal:  Prostate Cancer Prostatic Dis       Date:  2006-05-09       Impact factor: 5.554

2.  Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma.

Authors:  G D Demetri; C D Fletcher; E Mueller; P Sarraf; R Naujoks; N Campbell; B M Spiegelman; S Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

3.  Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma.

Authors:  Michael I Koukourakis; Alexandra Giatromanolaki; Adrian L Harris; Efthimios Sivridis
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

Review 4.  Tumor metabolism as modulator of immune response and tumor progression.

Authors:  Eva Gottfried; Marina Kreutz; Andreas Mackensen
Journal:  Semin Cancer Biol       Date:  2012-03-03       Impact factor: 15.707

5.  Caveolin-1-/- null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts.

Authors:  Federica Sotgia; Francesco Del Galdo; Mathew C Casimiro; Gloria Bonuccelli; Isabelle Mercier; Diana Whitaker-Menezes; Kristin M Daumer; Jie Zhou; Chenguang Wang; Sanjay Katiyar; Huan Xu; Emily Bosco; Andrew A Quong; Bruce Aronow; Agnieszka K Witkiewicz; Carlo Minetti; Philippe G Frank; Sergio A Jimenez; Erik S Knudsen; Richard G Pestell; Michael P Lisanti
Journal:  Am J Pathol       Date:  2009-03       Impact factor: 4.307

6.  The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin.

Authors:  Hilary A Kenny; Swayamjot Kaur; Lisa M Coussens; Ernst Lengyel
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

7.  Adipose triglyceride lipase contributes to cancer-associated cachexia.

Authors:  Suman K Das; Sandra Eder; Silvia Schauer; Clemens Diwoky; Hannes Temmel; Barbara Guertl; Gregor Gorkiewicz; Kuppusamy P Tamilarasan; Pooja Kumari; Michael Trauner; Robert Zimmermann; Paul Vesely; Guenter Haemmerle; Rudolf Zechner; Gerald Hoefler
Journal:  Science       Date:  2011-06-16       Impact factor: 47.728

8.  Arginase II expressed in cancer-associated fibroblasts indicates tissue hypoxia and predicts poor outcome in patients with pancreatic cancer.

Authors:  Yoshinori Ino; Rie Yamazaki-Itoh; Seiji Oguro; Kazuaki Shimada; Tomoo Kosuge; Jan Zavada; Yae Kanai; Nobuyoshi Hiraoka
Journal:  PLoS One       Date:  2013-02-12       Impact factor: 3.240

Review 9.  Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer.

Authors:  E D Michelakis; L Webster; J R Mackey
Journal:  Br J Cancer       Date:  2008-09-02       Impact factor: 7.640

10.  Metformin limits the adipocyte tumor-promoting effect on ovarian cancer.

Authors:  Calvin Tebbe; Jasdeep Chhina; Sajad A Dar; Kalli Sarigiannis; Shailendra Giri; Adnan R Munkarah; Ramandeep Rattan
Journal:  Oncotarget       Date:  2014-07-15
View more
  42 in total

1.  Loss of BRCA1 in the Cells of Origin of Ovarian Cancer Induces Glycolysis: A Window of Opportunity for Ovarian Cancer Chemoprevention.

Authors:  Tatsuyuki Chiyoda; Peter C Hart; Mark A Eckert; Stephanie M McGregor; Ricardo R Lastra; Ryuji Hamamoto; Yusuke Nakamura; S Diane Yamada; Olufunmilayo I Olopade; Ernst Lengyel; Iris L Romero
Journal:  Cancer Prev Res (Phila)       Date:  2017-03-06

Review 2.  Cancer as a Matter of Fat: The Crosstalk between Adipose Tissue and Tumors.

Authors:  Ernst Lengyel; Liza Makowski; John DiGiovanni; Mikhail G Kolonin
Journal:  Trends Cancer       Date:  2018-04-05

Review 3.  Watch What You (Self-) Eat: Autophagic Mechanisms that Modulate Metabolism.

Authors:  Vikramjit Lahiri; Wayne D Hawkins; Daniel J Klionsky
Journal:  Cell Metab       Date:  2019-04-02       Impact factor: 27.287

Review 4.  Targeting Metabolic Cross Talk between Cancer Cells and Cancer-Associated Fibroblasts.

Authors:  Jin G Jung; Anne Le
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

5.  Mesothelial Cell HIF1α Expression Is Metabolically Downregulated by Metformin to Prevent Oncogenic Tumor-Stromal Crosstalk.

Authors:  Peter C Hart; Hilary A Kenny; Niklas Grassl; Karen M Watters; Lacey M Litchfield; Fabian Coscia; Ivana Blaženović; Lisa Ploetzky; Oliver Fiehn; Matthias Mann; Ernst Lengyel; Iris L Romero
Journal:  Cell Rep       Date:  2019-12-17       Impact factor: 9.423

6.  Lactate as a predictive marker for tumor recurrence in patients with head and neck squamous cell carcinoma (HNSCC) post radiation: a prospective study over 15 years.

Authors:  Sebastian Blatt; Nadine Voelxen; Keyvan Sagheb; Andreas Max Pabst; Stefan Walenta; Thies Schroeder; Wolfgang Mueller-Klieser; Thomas Ziebart
Journal:  Clin Oral Investig       Date:  2016-01-04       Impact factor: 3.573

7.  Inhibition of fascin in cancer and stromal cells blocks ovarian cancer metastasis.

Authors:  Sean McGuire; Betul Kara; Peter C Hart; Anthony Montag; Kristen Wroblewski; Sarah Fazal; Xin-Yun Huang; Ernst Lengyel; Hilary A Kenny
Journal:  Gynecol Oncol       Date:  2019-02-20       Impact factor: 5.482

8.  Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity.

Authors:  Peter C Hart; Preety Bajwa; Hilary A Kenny
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 9.  Cancer's Fuel Choice: New Flavors for a Picky Eater.

Authors:  Gina M DeNicola; Lewis C Cantley
Journal:  Mol Cell       Date:  2015-11-19       Impact factor: 17.970

Review 10.  The multifaceted roles of fatty acid synthesis in cancer.

Authors:  Florian Röhrig; Almut Schulze
Journal:  Nat Rev Cancer       Date:  2016-09-23       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.